NTHI Latest Press Releases

-- November 2, 2026 --

NeOnc Is Putting Two Brain Cancer Programs on the Global Stage Globe Newswire 11:00 AM

NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology Globe Newswire 8:00 AM

-- October 30, 2026 --

NeOnc's Ambitious Brain Cancer Plans are Setting the Stage Globe Newswire 9:10 AM

-- October 29, 2026 --

2027 Could Finally Be the Year Cancer Is on the Ropes! Globe Newswire 9:10 PM

-- October 26, 2026 --

Defining Moments in the Race for Biotech Breakthroughs Globe Newswire 10:44 AM

NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries Globe Newswire 9:19 AM

-- October 23, 2026 --

NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue Globe Newswire 1:01 PM

-- October 22, 2026 --

Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly's Next Growth Chapter Globe Newswire 2:27 PM

NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight Globe Newswire 9:28 AM

NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy Globe Newswire 8:00 AM

-- October 21, 2026 --

Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market Globe Newswire 10:40 AM

NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward Globe Newswire 9:35 AM

NeOnc Technologies and the Department of Health - Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration Globe Newswire 8:00 AM

-- October 20, 2026 --

Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season Globe Newswire 9:33 AM

-- October 16, 2026 --

NeOnc's Boldest Test Yet: Child's Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone Globe Newswire 8:56 AM

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi Globe Newswire 8:00 AM

-- October 15, 2026 --

From Shaq to Musk: The Power Appointment Effect Globe Newswire 9:35 AM

UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances Globe Newswire 8:57 AM

NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026 Globe Newswire 8:00 AM

-- October 14, 2026 --

NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development Globe Newswire 10:18 AM

NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors Globe Newswire 8:00 AM

-- October 7, 2026 --

2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope Globe Newswire 9:59 AM

NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer Globe Newswire 9:43 AM

-- October 6, 2026 --

NeOnc's FDA Catalyst Run Could Give NTHI a Serious Jolt Globe Newswire 9:02 AM

-- October 5, 2026 --

Biotech Brainiacs and Breakthroughs Globe Newswire 9:51 AM

-- October 2, 2026 --

These High-Voltage Stocks Are Suddenly Impossible to Ignore Globe Newswire 11:44 AM

-- September 30, 2026 --

3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours Globe Newswire 10:22 AM

-- September 29, 2026 --

High-Stakes October has these Biotechs Entering Crucial Stretch Globe Newswire 12:12 PM

NeOnc's Powerful Brain Cancer Pipeline Advances Globe Newswire 8:52 AM

-- September 28, 2026 --

4 Explosive Stories Enter the Investor Spotlight Globe Newswire 11:51 AM

Powerful NeOnc Brain Cancer Pipeline Advances Globe Newswire 9:51 AM

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212 Globe Newswire 8:00 AM

-- September 24, 2026 --

Here's What Investors Are Watching, Including $20 Price Target Bombshell Globe Newswire 11:43 AM

NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst Globe Newswire 10:20 AM

-- September 22, 2026 --

NeOnc's Delivery may Finally Change the Equation for Brain Cancer's Next Frontier Globe Newswire 2:52 PM

Today's Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals Globe Newswire 10:31 AM

-- September 21, 2026 --

NeOnc Charting New Nasal Route to Treating Brain Cancer Globe Newswire 8:00 AM

-- September 17, 2026 --

Four High-Impact Small Caps Enter the Spotlight Globe Newswire 11:37 AM

NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates Globe Newswire 8:54 AM

NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution Globe Newswire 8:00 AM

-- September 16, 2026 --

NeOnc's $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA Globe Newswire 8:46 AM

NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results Globe Newswire 8:00 AM

-- September 15, 2026 --

Investor Determination to Beat Cancer Puts NeOnc's Novel Therapies and Patented Platform in Focus Globe Newswire 9:53 AM

-- September 14, 2026 --

Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test Globe Newswire 9:07 AM

-- September 11, 2026 --

Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs Globe Newswire 8:45 AM

-- September 10, 2026 --

Big Pharma Setbacks Create a New Wave of Rebound Plays Globe Newswire 2:12 PM

-- September 9, 2026 --

Four Biotech Stories Heating Up Right Now Globe Newswire 11:55 AM

NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data Globe Newswire 9:35 AM

NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors Globe Newswire 8:00 AM

-- September 8, 2026 --

NeOnc' Phase 2 Data Could Put Cancer on the Ropes Globe Newswire 8:39 AM

-- August 28, 2026 --

NeOnc's Phase 2A Success Could Set the Stage for Something Much Bigger Globe Newswire 10:07 AM

-- August 26, 2026 --

NeOnc's Clinical Story Is Now the Main Event Globe Newswire 9:39 AM

-- August 18, 2026 --

NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't Globe Newswire 10:18 AM

-- August 17, 2026 --

These Nasdaq Stories Are Heating Up Globe Newswire 3:26 PM

NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results Globe Newswire 8:45 AM

-- August 14, 2026 --

These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started Globe Newswire 1:13 PM

-- August 13, 2026 --

The Nose Knows: Why NeOnc's Patent Portfolio Could Make NTHI More Than a One-Drug Biotech Globe Newswire 2:31 PM

-- August 12, 2026 --

Powerful Catalysts Sending These Stocks into High Gear Globe Newswire 2:10 PM

Targeting The Mutant: NTHI's NEO100 Data Could Open a New Front in the Fight Against Brain Cancer Globe Newswire 9:38 AM

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma Globe Newswire 8:00 AM

-- August 11, 2026 --

These Have the Market Hot Zone Catalysts and Setups Globe Newswire 4:52 PM

Breakout Stocks and Next Big Movers Could Be Taking Shape Now Globe Newswire 2:44 PM

NeOnc Approaches a Major Biotech Inflection Point as tomorrow's Brain-Cancer Data is set to Collide with a Tight Float Globe Newswire 11:00 AM

-- August 10, 2026 --

The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones Globe Newswire 10:39 AM

NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears Globe Newswire 10:34 AM

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout Globe Newswire 9:00 AM

NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma Globe Newswire 8:30 AM

-- August 6, 2026 --

Why Investors Are Watching These Healthcare Movers Globe Newswire 12:31 PM

-- July 27, 2026 --

NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors Globe Newswire 9:00 AM

-- July 15, 2026 --

Three Biotechs Deliver Catalysts to Watch Globe Newswire 10:42 AM

NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition Globe Newswire 9:00 AM

-- July 1, 2026 --

Wall Street is Watching These Biotechs Globe Newswire 9:32 AM

-- June 25, 2026 --

The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution Globe Newswire 11:39 AM

-- June 24, 2026 --

NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum Globe Newswire 8:45 AM

-- June 23, 2026 --

These Emerging Companies Are Racing Toward Major Catalysts Globe Newswire 11:11 AM

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone Globe Newswire 9:00 AM

-- June 22, 2026 --

International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma Globe Newswire 9:05 AM

-- June 17, 2026 --

Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers Globe Newswire 10:37 AM

NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 Globe Newswire 9:18 AM

-- June 16, 2026 --

Wall Street Chases the Next Big Breakout Globe Newswire 3:22 PM

Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND Globe Newswire 1:49 PM

Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum Globe Newswire 10:18 AM

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development Globe Newswire 9:00 AM

-- June 12, 2026 --

From Nokia to NeOnc: The Stocks Dominating Screens as Volume Spikes Globe Newswire 11:40 AM

-- June 3, 2026 --

The Multi-Billion-Dollar Search for Better Glioblastoma Treatments Globe Newswire 9:28 AM